Document is current
Any future updates will be listed below
-
Authors
Thai, Michelle https://orcid.org/0000-0003-1520-6047
Olson, Elizabeth A.
Nickels, Stefanie
Dillon, Daniel G. https://orcid.org/0000-0002-1977-700X
Webb, Christian A. https://orcid.org/0000-0002-8310-4539
Ren, Boyu
Killgore, William D. S.
Rauch, Scott L.
Rosso, Isabelle M.
Pizzagalli, Diego A. https://orcid.org/0000-0002-7772-1143
- License Information
-
More Information
Article History
Received: 28 September 2023
Revised: 24 June 2024
Accepted: 10 July 2024
First Online: 23 July 2024
Competing interests
: • MT, IMR, CAW, BR, & WDSK report no biomedical financial interests or potential conflicts of interest. • EAO is an employee of Crisis Text Line, a nonprofit organization. • Over the past 3 years, Dr. Pizzagalli has received consulting fees from Boehringer Ingelheim, Compass Pathways, Engrail Therapeutics, Neumora Therapeutics (formerly BlackThorn Therapeutics), Neurocrine Biosciences, Neuroscience Software, Otsuka, Sage Therapeutics, Sama Therapeutics, and Takeda; he has received honoraria from the American Psychological Association, Psychonomic Society and Springer (for editorial work) and from Alkermes; he has received research funding from the Bird Foundation, Brain and Behavior Research Foundation, Dana Foundation, Millennium Pharmaceuticals, NIMH, and Wellcome Leap; he has received stock options from Compass Pathways, Engrail Therapeutics, Neumora Therapeutics, and Neuroscience Software. • SLR is employed by Mass General Brigham/McLean Hospital; he is paid as secretary of Society of Biological Psychiatry, and has received payment for Board service to Community Psychiatry/Mindpath Health and also for Board service to National Association of Behavioral Healthcare. He has served as a volunteer member of the Board for Anxiety & Depression Association of America, and The National Network of Depression Centers. He has received royalties from Oxford University Press, Springer Publishing, and American Psychiatric Publishing Inc. He has received research funding from NIMH and the US Army Military Operational Medicine Research Program (Award # W81XWH-12-1-0109; as noted above). • DD has received consulting fees from Pfizer, Inc., and from The Many Brains Project for work unrelated to the current study. • Over the past 3 years, SN was an employee of and owned equity in Verily Life Sciences. • No funding from these entities was used to support the current work, and all views expressed are solely those of the authors.
